Navtemadlin (KRT-232) in combination with avelumab for patients with anti-PD-1/L1 treatment-naïve TP53(WT) Merkel cell carcinoma (MCC) Meeting Abstract
| Authors: | Wong, M. K.; Burgess, M.; Chandra, S.; Schadendorf, D.; Silk, A.; Olszanski, A. J.; Grob, J. J.; Jang, S.; Grewal, J. S.; Lewis, K. D.; Fecher, L.; Rabinowits, G.; Lebbe, C.; Martin-Liberal, J.; Di Giacomo, A. M.; Friedlander, P.; Brohl, A. S.; Croft, B.; McGreivy, J. S.; Rothbaum, W. P.; Hanna, G. J.; Kelly, C. M. |
| Abstract Title: | Navtemadlin (KRT-232) in combination with avelumab for patients with anti-PD-1/L1 treatment-naïve TP53(WT) Merkel cell carcinoma (MCC) |
| Meeting Title: | 2nd International Merkel Cell Carcinoma Symposium |
| Journal Title: | Journal of Investigative Dermatology |
| Volume: | 142 |
| Issue: | 10 |
| Meeting Dates: | 2022 Apr 25-26 |
| Meeting Location: | Seattle, WA |
| ISSN: | 0022-202X |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | 2841 |
| Language: | English |
| ACCESSION: | WOS:000888821100034 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jid.2022.08.027 |
| Notes: | Meeting Abstract -- Source: Wos |
